Cancer Risk in Patients with Hereditary Hemochromatosis and in Their First-Degree Relatives

Gastroenterology

Volumn 125, Issue 6, 2003, Pages 1733-1741

  Elmberg, Maria ^a   Hultcrantz, Rolf ^a   Ekbom, Anders ^a   Brandt, Lena ^a   Olsson, Sigvard ^b   Olsson, Rolf ^b   Lindgren, Stefan ^c   Lööf, Lars ^d   Stal, Per ^e   Wallerstedt, Sven ^b   Almer, Sven ^f   Sandberg Gertzén, Hanna ^g   Askling, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e DANDERYD HOSPITAL   (Sweden)

^f Linkoping Hospital   (Sweden)

^g ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CARCINOGENICITY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC DISORDER; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; IRON OVERLOAD; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; SEX DIFFERENCE; SWEDEN;

EID: 10744232491     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.09.035     Document Type: Article

References (39)

1. Cardoso EMP, Stàl P, Hagen K, Cabeda JM, Esin S, de Sousa M, Hultcrantz R. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998;243:203-208.
2. Jawinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP. Haemochromatosis and HLA-H. Nat Genet 1996;14:249-250.
3. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn G, Andrieux N, Gicquel I, Le Gall JY, David V. Haemochromatosis and HLA-H. Nat Genet 1996;14:251-252.
4. Brissot P, Moirand R, Jouanolle AM, Guyader D, Le Gall JY, Deugnier Y, David V. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 1999;30:588-593.
5. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-1362.
6. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet 2002;359:211-218.
7. Ryan E, Byrnes V, Coughlan B, Flanagan AM, Barrett S, O'Keane JC, Crowe J. Underdiagnosis of hereditary hemochromatosis: lack of presentation or penetration? Gut 2002;51:108-112.
8. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Am J Epidemiol 2001;154:193-206.
9. Lucotte G. Frequency analysis and allele map in favor of the Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 2001;27:549-556.
10. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis, N Engl J Med 1985;313:1256-1262.
11. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med 1998;129:946-953.
12. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, Halliday JW, Bassett ML, Powell LW. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst 1985;75:81-84.
13. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, Fraumeni JF Jr. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 1995; 60:160-162.
14. Tiniakos G, Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Appl Pathol 1988;6:128-138.
15. Shaheen NJ, Silverman LM, Keku T, Lawrence LB, Rohlfs EM, Martin CF, Galanko J, Sandler RS. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst 2003;95:154-159.
16. Ammann RW, Muller E, Bansky J, Schuler G, Hacki WH. High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand J Gastroenterol 1980;15:733-736.
17. Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, Fargion S. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 2001;33:647-651.
18. Nelson LR, Davis FG, Persky V, Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995;76:875-879.
19. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med 1988;319:1047-1052.
20. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994;56:379-382.
21. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-1805.
22. de Valk B, Witlox RS, van der Schouw YT, Marx JJ. Biochemical expression of heterozygous hereditary hemochromatosis. Eur J Intern Med 2000;11:317-321.
23. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114: 1003-1008.
24. Höhler T, Leininger S, Kohler HH, Schirmacher P, Galle PR. Heterozygosity for the hemochromatosis gene in liver disease-prevalence and effects on liver histology. Liver 2000;20:482-486.
25. Centre for Epidemiology, National Board of Health and Welfare. The Swedish Inpatient Register 1987-1995. Stockholm, 1997.
26. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark and Israel. Vital Health Stat-2 1980;2:1-59.
27. Mattson B, Wallgren A. Completeness of the Swedish cancer register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-313.
28. Hulten L, Gramatkovski E, Gleerup A, Hallberg L. Iron absorption from the whole diet: relation to meal composition, iron require-ments and iron stores. Eur J Clin Nutr 1995;49:794-808.
29. Fargion S, Fracanzani AL, Piperno A, Braga M, D'Alba R, Ronchi G, Fiorelli G. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology 1994;20:1426-1431.
30. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101: 368-373.
31. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
32. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-659.
33. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996;20:553-566.
34. Deshpande A, Narayanan PK, Lehnert BE. Silica-induced generation of factor(s) increases reactive oxygen species in human bronchial epithelial cells. Toxicol Sci 2002;67:275-283.
35. Van Asperen IA, Feskens EJM, Bowles CH, Kromhout D. Body iron stores and mortality due to cancer and ischemic heart disease: a 17-year follow-up study of elderly men and women. Int J Epidemiol 1995;24:665-670.
36. Macdonald GA, Tarish J, Whitehall VJ, McCann SJ, Mellick GD, Buttenshaw RL, Johnson AG, Young J, Leggett BA. No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. J Gastroenterol Hepatol 1999;14:1188-1191.
37. Beckman LE, Van Landeghem GF, Sikström C, Wahlin A, Markeväm B, Hallmans G, Lenner P, Athlin L, Stenling R, Beckman L. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 1999; 20:1231-1233.
38. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:563-565.
39. Bostrom G. Chapter 6. Habits of life and public health. Health in Sweden: the National Public Health Report 2001. Scand J Public Health 2001;(suppl 58):133-166.